|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The HELLP Syndrome at 16 weeks'Gestation:Possible Association with the Antiphospholipid Syndrome显示文摘 | McMahon LP Smith J | | 0，，03： | 1 |
| 2 | Effects of haemoglobin normalization on quality of life and cardiovascular parameters in end stage renal failure显示文摘 | McMahon LP Mason K Skinner SL et al | 2000 | Nephrol Dial Transplant2000，15，： | 1 |
| 3 | Effects of different dialysis membranes on serum concentrations of epoetin aIfa, darbepoetin alfa, enoxaparin, and iron sucrose during dialysis 显示文摘 | McMahon LP Chester K Walker RG | 2004 | Am J Kidney Dis2004，44，： | 1 |
| 4 | Effects of hemoglobin normalization on quality of life and cardiovascular parameters in end-stage renal failure 显示文摘 | McMahon LP Mason K Skinner SL | 2000 | Nephrol Dial Transplant2000，15，9： | 1 |
| 5 | Phannacokinetic studies of dalteparin ( Fragmin ), enoxaparin ( Clexane ), and danaparoid sodium (Orgaran) in stable chronic hemodialysis patients 显示文摘 | Polkinghome KR McMahon LP Becker GJ | 2002 | Am J Kidney Dis2002，40，5： | 1 |
| 6 | Two motifs in the translational repressor PHAS-I required for efficient phosphorylation by mammalian target of rapamycin and for recognition by raptor显示文摘 | Hoi KM McMahon LP Jr Lawrence JC | 2003 | J Biol Chem2003，278，19： | 1 |
| 7 | Pharmacokinetic studies of dalteparin ( Fragmin ), enoxaparin ( Clexane ), and danaparoid sodium ( Orgaran )in stable chronic hemodialysis patients显示文摘 | Polkinghorne KR McMahon LP Becker GJ | 2002 | Am J Kidney Dis2002，40，5： | 1 |
| 8 | Effects of different dialysismembranes on serum concentrations of epoetin alfa, arbepoetinalfa, enoxaparin, and iron sucrose during dialysis 显示文摘 | McMahon LP Chester K Walker RG | 2004 | Am J Kidney Dis2004，44，： | 1 |
| 9 | The rapamycin-binding domain governs substrate selectivity by mammalian target of rapamycin显示文摘 | McMahon LP Choi KM Lin TA | 2002 | Mol Cell Biol2002，22，21： | 1 |
| 10 | Fetuin-A-con- taining calciprotein particles reduce mineral stress in the maerophage 显示文摘 | Smith ER Hanssen E McMahon LP | 2013 | PLoS One2013，8，60： | 1 |
| 11 | Serum fetuin-A concentration and fetuin-A-containing calciprotein particles in patients with chronic inflammatory disease and renal failure 显示文摘 | Smith ER Cai MM McMahon LP | 2013 | Nephrology (Carlton)2013，18，3： | 1 |
| 12 | Pharmacokinetic studies of dalteparin ( Fragmin), enoxaparin ( Clexane ), and danaparoid sodium (Orgaran) in stable chronic hemodialysis patients, A 显示文摘 | Polkinghorne KR McMahon LP Becker GJ | 2002 | J Kid Dis2002，40，： | 1 |
| 13 | Biological vari- ability of plasma intact and C-terminal FGF23 measure- ments显示文摘 | Smith ER Cai MM McMahon LP | 2012 | J Clin Endocrinol ietab2012，97，： | 1 |
| 14 | ethod-specific differ- ences in plasma fibroblast growth factor 23 measure- ment using four commercial ELISAs显示文摘 | Smith ER McMahon LP Holt SG | 2013 | Clin Chem Lab Med2013，51，： | 1 |
| 15 | The rapamycin-binding domain governs substrate selectivity by the mammalian target of rapamycin显示文摘 | McMahon LP Choi KM Lin TA | | 0，，21： | 1 |
| 16 | Famesylthiosalicylic acidinhibits mammalian target of rapamycin ( mTOR) activity both incells and in vitro by promoting dissociation of the mTOR - raptorcomplex 显示文摘 | McMahon LP Yue W Santen RJ | 2005 | Mol Endocrinol2005，19，1： | 1 |
| 17 | Effects of haemoglobin normalization on quality of life and cardiovascular parameters in end-stage renal failure显示文摘 | Mason K Skinner SL | 2000 | Nephrol Dial Transplant2000，15，9： | 1 |
| 18 | The rapamycin-binding domain governs substrate selectivity by mammalian target of rapamcin显示文摘 | Choi KM Lin TA | 2002 | Mol Cell Biol2002，22，21： | 1 |
| 19 | Method-specific differences in plasma fibroblast growth factor 23 measurement using four commercial ELISAs显示文摘 | Smith ER McMahon LP Holt SG | 2013 | Clin Chem Lab Med2013，51，10： | 1 |
| 20 | Physical performance and associated electrolyte changes after haemoglobin normalization: a comparative study inhaernodialysis patients 显示文摘 | McKenna MJ Sangkabutra T | 1999 | Nephrol Dial Transplant1999，14，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员